$IONQ

Varonis Systems (VRNS) rose 2.5% after Proofpoint agreed to acquire it for ~$6.3B. International Paper (IP) gained 7.4% on reports of potential bids for its European packaging business. CCC (CCC) will be acquired for ~$6.1B, Galderma (GALDY) will buy ZO Skin Health for $1.5B, and Bumble (BMBL) surged 57% on a $1.3B acquisition deal. IonQ (IONQ) is acquiring Elisity for up to $1.3B, and STERIS (STE) will buy Xodus Medical for $2.1B.

IonQ agreed to sell 20.5M shares, 29.5M pre-funded warrants, and 100M Series C warrants at $40 per unit. Each share or pre-funded warrant is paired with two Series C warrants, exercisable immediately for seven years. Series C warrants have an exercise price of $69.46, while pre-funded warrants have an exercise price of $0.0001. The offering is underwritten by J.P. Morgan, according to the company's SEC filing.

IonQ, Inc. (IONQ) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On October 14, 2026, IonQ, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC as the sole underwriter, providing for the offer and sale of (i) 20,500,000 shares (the “Shares”) of the C

Bumble (BMBL) agreed to a $1.3B all-cash acquisition by Ithaca Holdings, becoming privately held. IonQ will acquire Elisity in an all-stock deal up to $1.3B. Agilent (A) to buy Proscia for $240M. Workday (WDAY) acquiring C1.ai. Aurora Cannabis exploring alternatives to Curaleaf's bid. Character.ai filed for bankruptcy, Disney to pay $20M for IP. Getty Images plans Chapter 11, going private with Koch backing.

Quantum computing companies report varying revenue and financial health. IonQ (IONQ) generated $80.1M in Q2, while D-Wave (QBTS) and Rigetti (RGTI) reported $3M and $5.1M, respectively. IBM (IBM) invests heavily but doesn't separate quantum revenue. IonQ shows revenue growth but high cash burn. D-Wave and Rigetti rely on stock sales for funding. Alphabet and Nvidia (NVDA) are involved but not yet selling quantum products.

IONQ Inc. disclosed $110,000 in lobbying expenses for Q3 2026, focusing on quantum-related appropriations. Insiders sold 14,236 shares totaling $714,439 in the past 6 months. Hedge funds showed mixed activity, with some increasing and others decreasing their positions. Analysts' price targets for IONQ range from $50 to $100, with a median of $72.5.

Cullen/Frost Bankers (CFR) fell 2.6% after a price target cut. Bank of America (BAC) dropped 7.4% due to earnings miss and penalty. State Street (STT) declined 9.8% on revenue shortfall. Hewlett Packard Enterprise (HPE) fell 5.2% following a downgrade. IonQ (IONQ) dropped 5.2% after a $2.0B equity offering.

Quantum computing stocks IonQ (IONQ), Rigetti (RGTI), and D-Wave (QBTS) rebounded 2-3% after a dilution scare. IonQ's $2B equity offering priced below market, causing a drop. Despite a 28% YTD decline, IonQ reported Q2 2026 revenue of $80.05M, up 286.8% YoY, and raised FY 2026 guidance to $280-290M. The company remains unprofitable with a $3.43 per share loss over the past year.

IonQ (IONQ) agreed to acquire Elisity for $1.3B, aiming to develop quantum-proof security. The company focuses on trapped-ion quantum computing and plans to release a 256-qubit computer in 2027. Despite the acquisition, its stock fell 10%.

IonQ's average price target dropped slightly from $68.54 to $68.08, with estimates ranging from $43 to $100. This implies 117% upside from the Oct. 14 close. 16 analysts maintain a 'Buy' consensus, with 13 Buys, 3 Holds, and 0 Sells.